Current Share price, page-35

I was a stockbroker for 11 years before being a CFO.

I don’t make price calls.

Particularly in companies with such a short earnings record.

Making price calls is for charlatans and noobs.

TA is silly voodoo for the gullible.

Fundamental analysis requires years of earnings, accomplishment and execution history. It also requires management that is stable and has long served.

None of that applies to ANY cannabis stocks, including EOF.

TA on a company that’s been trading 6 weeks is the funniest voodoo joke ever told.

So yes, we’ll go up or down from here. My horizon is 5 years out.

I DO think it will be up. We have the germ plasm, and Monsanto or some other pharma will want it. That’s my call.